Rats susceptible to virus-induced asthma have a persistent virus-induced change in the predominant pulmonary form of the NF-κB inhibitor IκBα

Veterinary Pathology

Volumn 47, Issue 6, 2010, Pages 1021-1027

  Uhl, E W ^a   Clarke, T J ^b   Lester, C ^a   Hogan, R J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b Leica Microsystems Inc   (United States)

Author keywords

asthma; I7kappa; ; NF B; rat model; Sendai virus

Indexed keywords

BROXURIDINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL; ARTICLE; ASTHMA; BROWN NORWAY RAT; DRUG ANTAGONISM; FISCHER 344 RAT; LUNG; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; RESPIROVIRUS INFECTION; SENDAI VIRUS; SPECIES DIFFERENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIROLOGY; WESTERN BLOTTING;

ANIMALS; ASTHMA; BLOTTING, WESTERN; BROMODEOXYURIDINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; I-KAPPA B PROTEINS; LUNG; MALE; NF-KAPPA B; RATS; RATS, INBRED BN; RATS, INBRED F344; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; SPECIES SPECIFICITY;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; SENDAI VIRUS;

EID: 78649958330     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810382521     Document Type: Article

References (19)

1. Cai X., Castleman WL: Early high expression of IP-10 in F344 rats resistant to Sendai virus-induced airway injury. Am J Physiol Lung Cell Mol Physiol 285:L1263-L1269, 2003.
2. Edwards MR, Bartlett NW, Clarke D., Birrell M., Belvisi M., Johnston SL: Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 121: 1-13, 2009.
3. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E., Carlson-Dakes KT, Salazar LP, Dasilva DF, Tisler CJ, Gern JE, Lemanske RF Jr: Wheezing rhinovirus illnesses in early life predict asthma development in high risk children. Am J Respir Crit Care Med 178:667-672, 2008.
4. Kanayama A., Inoue J., Sugita-Konishi Y., Shimizu M., Miyamoto Y.: Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 277:24049-24056, 2002.
5. Kumar A., Sorkness RL, Kaplan MF, Lemanske RF: Chronic, episodic, reversible airway obstruction after viral bronchiolitis in rats. Am J Respir Crit Care Med 155:130-134, 1997.
6. Mehta H., Sorkness RL, Kaplan MR, Castleman WL, Lemanske RF: Effects of dexamethasone on acute virus-induced airway dysfunction in adult rats. Pediatr Res 41:872-877, 1997.
7. Midwinter RG, Cheah FC, Moskovitz J., Vissers MC, Winterbourn CC: IkappaB is a sensitive target for oxidation by cell-permeable chloramines: inhibition of NF-kappaB activity by glycine chloramine through methionine oxidation. Biochem J 396:71-78, 2006.
8. Ogino T., Hosako M., Hiramatsu K., Omori M., Ozaki M., Okada S.: Oxidative modification of IkappaB by monochloramine inhibits tumor necrosis factor alpha-induced NF-kappaB activation. Biochim Biophys Acta 1746:135-142, 2005.
9. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B.: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161:1501-1507, 2000.
10. Sorden SD, Castleman WL: Brown Norway rats are high responders to bronchiolitis, pneumonia and bronchiolar mastocytosis induced by parainfluenza virus. Exp Lung Res 17:1025-1045, 1991.
11. Sorkness RL, Castleman WL, Kumar MR, Kaplan MR, and Lemanske RF: Prevention of chronic postbronchiolitis airway sequella with IFN-γ treatment in rats. Am J Respir Crit Care Med 160:705-710, 1999.
12. Sorkness RL, Lemanske RF, Castleman WL: Persistent airway hyperresponsiveness following neonatal viral bronchiolitis in rats. J Appl Physiol 191:375-383, 1991.
13. Stone AE, Giguere S., Castleman WL: IL-12 reduces the severity of Sendai virus-induced bronchiolar inflammation and remodeling. Cytokine 24:103-113, 2003.
14. Tokunaga S., Kanayama A., Miyamoto Y.: Modification of Ikappa-Balpha by taurine bromamine inhibits tumor necrosis factor alpha-induced NF-kappaB activation. Inflamm Res 56:479-486, 2007.
15. Uhl EW, Clarke TJ, Hogan RJ: Differential expression of nuclear factor-kB (NF-kB) associated with increased pulmonary expression of tumor necrosis factor-α (TNF-α) in a rat model of virus-induced asthma. Viral Immunol 2:79-89, 2009.
16. 1) expression. Am J Respir Crit Care Med 154:1834, 1996.
17. Uhl EW, Moldawer LL, Busse WW, Jack TJ, Castleman WL: Increased tumor necrosis factor-α (TNF-α) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis. Am J Pathol 152:513-522, 1998.
18. Weil R., Laurent-Winter C., Israel A.: Regulation of Ikα degradation. J Biol Chem 272:9942-9949, 1997.
19. Viatour P., Legrand-Poels S., van Lint C., Warnier M., Merville MP, Gielen J., Piette J., Bours V., Chariot A.: Cytoplasmic Ikα increases NF-kB-independent transcription through binding to histone deacetylase (HDAC)1 and HDAC3. J Biol Chem 47:46541-46548, 2003.